Results 191 to 200 of about 66,967,971 (330)

"Discriminated labor" bangs on the government's door [PDF]

, 1998
Research, Update
core  

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Facilitating research participation through a research navigator programme: researchers' insights from a project with asylum seekers and refugees. [PDF]

Confl Health
A HM, M T, H E, M M.
europepmc   +1 more source

Editorial

Drug Analytical Research, 2022
Drug Analytical Research
doaj  

Third Kurultai held in simferopol [PDF]

, 1999
Research, Update
core  

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

Molecular Oncology, EarlyView.
This study highlights the potential of automated enumeration using the ACCEPT software to refine circulating tumor cell (CTC) detection in metastatic colorectal cancer (mCRC). The automated method demonstrates improved accuracy and reduced variability compared to the manual approach.
Michela De Meo, Marco Siringo, Alessandro Vici, Ann Zeuner, Orietta Gandini, Paola Gazzaniga, Chiara Nicolazzo   +6 more
wiley   +1 more source

Reduction of Afterdrop by Using Active External Warming During Treatment of Accidental Hypothermia-A Randomized, Crossover Trial. [PDF]

Acta Anaesthesiol Scand
Mydske S, Helland AM, Borasio N, Brattebø G, Østerås Ø, Wiggen Ø, Assmus J, Strapazzon G, Thomassen Ø.   +8 more
europepmc   +1 more source

President gets a new political council [PDF]

, 2001
Research, Update
core  

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Gaining insights into a funding portfolio through publication tracking. [PDF]

NIHR Open Res
Suri-Ogilvie R, Hicks S, Capostagno D, Banks A, Ahmed E, Makarona K.   +5 more
europepmc   +1 more source